[1] |
Khali MI, Alzahrani MH, Ullah A. The use of cervical length and change in cervical length for prediction of spontaneous preterm birth in asymptomatic twin pregnancies[J]. Eur J Obstet Gynecol Reprod Biol, 2013, 169(2):193-196.
|
[2] |
Vink J, Wapner R, Dalton ME. Prenatal diagnosis in twin gestation[J]. Semin in Perinatol, 2012, 36(3):169-174.
|
[3] |
周祎. 双胎染色体非整倍体的产前筛查[J]. 实用妇产科杂志,2012, 28(5):328-330.
|
[4] |
刘志婷,王军荣,续微,等. 染色体多态性引起生殖异常36例分析[J]. 中华医学遗传学杂志,2006, 10(5):598-599.
|
[5] |
Rodis JF, Egan JF, Craffey A, et al. Calculated risk of chromosomal abnormalities in twin gestions[J]. Obstet Gynecol, 1990, 76(6):1037-1041.
|
[6] |
Bahado-Singh RO, Wapner R, Thom E, et al. Elevated frst-rimester nuchal translucency increases the risk of congenital heart defects[J]. Am J Obstet Gynecol, 2005, 192(5):1357-1361.
|
[7] |
Westin M, Saltvedt S, Almstrom H, et al. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population[J]. Ultrasound Obstet Gynecol, 2007, 29(2):150-158.
|
[8] |
Snijider RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation[J]. Lancet. 1998,9125(351):343-346.
|
[9] |
Tahmasebpour A, Rafiee NB, Ghaffari S,et al. Increased nuchal translucency and pregnancy outcome[J]. Iran J Public Health, 2012, 41(11):92-97.
|
[10] |
Gagnon A, Audibert F. Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies. Joint SOGC-CCMG Clinical Practice Guidline NO 262[J]. J Obstet Gynaecol Can, 2011, 33(7): 754-767.
|
[11] |
Snijders RJ, Thom EA, Zachary JM, et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique[J]. Ultrasound Obstet Gynecol, 2002, 19(4): 353-359.
|
[12] |
Vandecruys H, Faiola S, Auer M, et al. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness[J]. Ultrasound Obstet Gynecol, 2005, 25(6):551-513.
|
[13] |
Sebire NJ, Souka A, Skentou H, et al. Early predition of severe twin-to-twin transfusion syndrome[J]. Hum Reprod, 2000, 15(9): 2008-2010.
|
[14] |
Wald NJ, Rish S, Hackshaw Ak. Combining nuchal translucency and serum marker in prenatal screening for Down syndrome in twin pregnancies[J]. Prenat Diagn, 2003, 23(7): 588-592.
|
[15] |
Wald NJ, Rish S. Prenatal screening for Down syndrome and neural tube defects in twin pregnancies[J]. Prenat Diagn, 2005, 25(9):740-745.
|
[16] |
段涛,胡亚莉,吕时铭. 产前诊断[M]. 北京:人民卫生出版社,2010:486.
|
[17] |
van den Berg C, Braat APG, Van Opstal D, et al. Amniocentesis or chorionic villus sampling in multiple gestations? Experience with 500 cases[J]. Prenat Diagn, 1999, 19(3):234-244.
|
[18] |
Antsaklis A, Souka AP, Daskalakis G, et al. Second-trimester amniocentesis vs chorionic villus sampling for prenataldiagnosis in multiple gestation[J]. Ultrasound Obstet Gynecol, 2002, 20(5):476-481.
|